Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.

Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS.

J Am Acad Dermatol. 2005 Feb;52(2):262-7. Review. Erratum in: J Am Acad Dermatol. 2005 Apr;52(4):670. Prodanowich, Srdjan [corrected to Prodanovich, Srdjan].

PMID:
15692471
2.

Infections during low-dose methotrexate treatment in rheumatoid arthritis.

Boerbooms AM, Kerstens PJ, van Loenhout JW, Mulder J, van de Putte LB.

Semin Arthritis Rheum. 1995 Jun;24(6):411-21. Review.

PMID:
7667645
3.

Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.

Whittle SL, Hughes RA.

Rheumatology (Oxford). 2004 Mar;43(3):267-71. Epub 2004 Jan 6. Review.

PMID:
14963199
4.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
5.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2013 May 31;(5):CD000951. doi: 10.1002/14651858.CD000951.pub2. Review.

PMID:
23728635
6.

Methotrexate update.

Kremer JM.

Scand J Rheumatol. 1996;25(6):341-4. Review.

PMID:
8996467
7.

Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?

McLean-Tooke A, Aldridge C, Waugh S, Spickett GP, Kay L.

Rheumatology (Oxford). 2009 Aug;48(8):867-71. doi: 10.1093/rheumatology/kep101. Epub 2009 May 15. Review.

PMID:
19447771
8.

Methotrexate in rheumatoid arthritis.

Swierkot J, Szechiński J.

Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Review.

9.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.

J Rheumatol. 2014 Jun;41(6):1049-60. doi: 10.3899/jrheum.130738. Epub 2014 Apr 15. Review.

PMID:
24737913
10.

Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Salaffi F, Manganelli P, Carotti M, Subiaco S, Lamanna G, Cervini C.

Clin Rheumatol. 1997 May;16(3):296-304. Review.

PMID:
9184269
11.

Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.

Blanco R, Martínez-Taboada VM, González-Gay MA, Armona J, Fernández-Sueiro JL, González-Vela MC, Rodríguez-Valverde V.

Arthritis Rheum. 1996 Jun;39(6):1016-20. Review.

PMID:
8651964
12.

Folate supplementation during methotrexate therapy for patients with psoriasis.

Strober BE, Menon K.

J Am Acad Dermatol. 2005 Oct;53(4):652-9. Review.

PMID:
16198787
13.

Methotrexate use in rheumatoid arthritis. A Clinician's perspective.

Alarcón GS.

Immunopharmacology. 2000 May;47(2-3):259-71. Review.

PMID:
10878293
14.

Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects.

Schnabel A, Gross WL.

Semin Arthritis Rheum. 1994 Apr;23(5):310-27. Review.

PMID:
8036521
15.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080
16.

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.

van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB.

Semin Arthritis Rheum. 1998 Apr;27(5):277-92. Review.

PMID:
9572710
17.

Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.

Georgescu L, Quinn GC, Schwartzman S, Paget SA.

Semin Arthritis Rheum. 1997 Jun;26(6):794-804. Review.

PMID:
9213378
18.

Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.

Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J.

Semin Arthritis Rheum. 2009 Oct;39(2):123-31. doi: 10.1016/j.semarthrit.2008.08.002. Epub 2008 Sep 27. Review.

PMID:
18823645
19.

[Methotrexate. Pharmacology applied to the treatment of rheumatoid arthritis].

Chassagne P, Levesque H, Moore N.

Therapie. 1990 Nov-Dec;45(6):499-504. Review. French.

PMID:
2080488
20.

Methotrexate: mechanism of action in rheumatoid arthritis.

Segal R, Yaron M, Tartakovsky B.

Semin Arthritis Rheum. 1990 Dec;20(3):190-200. Review.

PMID:
2287944

Supplemental Content

Support Center